Columbus, OH, United States of America

Michael Wagner

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Battelle Memorial Institute. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Wagner: Innovator in Polymer Nanoparticle Compositions

Introduction

Michael Wagner is an accomplished inventor based in Columbus, OH. He has made significant contributions to the field of polymer nanoparticle compositions, particularly in the therapeutic delivery of polypeptides. His innovative work has the potential to advance medical treatments and improve patient outcomes.

Latest Patents

Wagner holds a patent for "Polymer nanoparticle compositions for in vivo expression of polypeptides." This patent focuses on block copolymer nanoparticles designed for in vivo therapeutic delivery. More specifically, it relates to polymer nanoparticles, such as reversible addition-fragmentation chain transfer (RAFT) polymer compositions, which are utilized for delivering nucleotides that encode polypeptides. This invention represents a significant advancement in the field of drug delivery systems.

Career Highlights

Michael Wagner is currently employed at Battelle Memorial Institute, where he continues to work on innovative solutions in the realm of polymer science and therapeutic applications. His expertise and dedication to research have positioned him as a key figure in his field.

Collaborations

Wagner collaborates with Kenneth R Sims, Jr., further enhancing the research and development efforts at Battelle Memorial Institute. Their combined expertise contributes to the advancement of innovative technologies in therapeutic delivery.

Conclusion

Michael Wagner's contributions to polymer nanoparticle compositions exemplify the impact of innovation in the medical field. His work not only showcases his inventive spirit but also holds promise for future advancements in therapeutic delivery systems.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…